Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 45,849 | 52,609 | 67,430 | 66,918 | 0 |
| Cost of Goods | 12,964 | 20,361 | 20,988 | 19,820 | N/A |
| Gross Profit | 32,885 | 32,248 | 46,442 | 47,098 | N/A |
| Operating Expenses | 76,742 | 85,277 | 96,369 | 48,031 | 0 |
| Operating Income | -42,893 | -52,668 | -48,934 | -113 | N/A |
| Interest Expense | 13,022 | 9,318 | 7,711 | 7,707 | 0 |
| Other Income | 132 | -4,260 | -4,731 | -1,123 | 0 |
| Pre-tax Income | -55,783 | -66,246 | -61,376 | -8,943 | 0 |
| Net Income Continuous | -55,783 | -66,246 | -61,376 | -8,943 | N/A |
| Net Income | $-55,783 | $-66,246 | $-61,376 | $-8,943 | $N/A |
| EPS Basic Total Ops | -1.66 | -2.61 | -2.96 | N/A | N/A |
| EPS Basic Continuous Ops | -1.66 | -2.61 | -2.96 | N/A | N/A |
| EPS Diluted Total Ops | -1.66 | -2.61 | -2.96 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.66 | -2.61 | -2.96 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-36,863 | $-47,834 | $-44,007 | $5,548 | $N/A |